Structure Therapeutics Inc. (GPCR) — 8-K Filings

8-K Filings (17)

• Structure Therapeutics Files 8-K: Officer Changes & Reg FD — Apr 15, 2026 Risk: low
  Structure Therapeutics Inc. filed an 8-K on April 15, 2026, reporting on the departure of a director or officer, compensatory arrangements, and Regulation FD di
• 8-K Filing — Dec 10, 2025
• 8-K Filing — Dec 8, 2025
• 8-K Filing — Nov 6, 2025
• Structure Therapeutics Files 8-K on Financials — Aug 6, 2025 Risk: low
  Structure Therapeutics Inc. filed an 8-K on August 6, 2025, reporting on its results of operations and financial condition. The filing also includes financial s
• Structure Therapeutics Files 8-K on Shareholder Vote Matters — Jun 25, 2025 Risk: low
  Structure Therapeutics Inc. filed an 8-K on June 25, 2025, reporting on matters submitted to a vote of security holders as of June 23, 2025. The company, former
• Structure Therapeutics Files 8-K on Financials — May 8, 2025 Risk: low
  Structure Therapeutics Inc. filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing also includes financial stat
• Structure Therapeutics Files 8-K on Financials — Feb 27, 2025 Risk: low
  Structure Therapeutics Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing also includes financia
• Structure Therapeutics Files 8-K — Dec 17, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on December 17, 2024, reporting on financial statements and exhibits. The company, formerly known as ShouTi Inc. until
• Structure Therapeutics Files 8-K on Financials — Nov 13, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on November 13, 2024, reporting on its results of operations and financial condition. The filing also includes financia
• Structure Therapeutics Appoints New CMO and CDO — Sep 17, 2024 Risk: low
  Structure Therapeutics Inc. announced on September 12, 2024, the appointment of Dr. Jian-Hua Xu as Chief Medical Officer and Dr. Xiaojun Tang as Chief Developme
• Structure Therapeutics Appoints New Director — Aug 27, 2024 Risk: low
  Structure Therapeutics Inc. announced on August 24, 2024, a change in its board of directors. Specifically, Dr. Jianmin Feng has been appointed as a Class II Di
• Structure Therapeutics Files 8-K on Financials — Aug 8, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on August 8, 2024, reporting on its results of operations and financial condition. The filing also includes financial s
• Structure Therapeutics to be Acquired for $2.8 Billion — Jun 27, 2024 Risk: medium
  Structure Therapeutics Inc. announced on June 25, 2024, that it has entered into a definitive agreement to be acquired by D.E. Shaw & Co., L.P. for $2.8 billion
• Structure Therapeutics Files 8-K — Jun 3, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on June 3, 2024, reporting on other events and financial statements. The company, formerly known as ShouTi Inc. until O
• Structure Therapeutics Files 8-K on Financials — May 9, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition. The filing also includes financial stat
• Structure Therapeutics Files 8-K on Financials — Mar 8, 2024 Risk: low
  Structure Therapeutics Inc. filed an 8-K on March 8, 2024, reporting on its results of operations and financial condition. The filing also includes financial st

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX